Funder: Cures Within Reach
Due Dates: June 26, 2026: Letter of Intent deadline
Funding Amounts: Up to $100,000 per project (includes 10% institutional match); additional funds may be available for community engagement.
Summary: Supports global, investigator-initiated Phase I/IIA clinical trials that use AI-driven approaches to repurpose already approved therapies for any disease.